Top 5 Low Price Stocks To Buy Right Now

Citigroup’s Alastair Syme and team argue that the earnings from big oil companies like Chevron (CVX), Total (TOT) and Royal Dutch Shell (RDS.A) will be bad…real bad. But that won’t stop the stocks from outperforming. They explain why:

Bloomberg News

Negative headlines, positive performance: We expect the majority of Big Oil companies to post negative 1Q16 earnings, a brutal headline, but one that clearly reflects the impact of cyclical oil price lows this quarter. The outlook can improve. Our positive thesis on the Big Oil group reflects a belief that the market still only discounts modest oil recovery we think c. $40/bbl is imbedded in valuations and a view that the group can drive self-help gains to boost profitability even in a low price environment. Signs of this self-help should be evident in 1Q operating performance: we expect to see the delivery of top-line growth (taking market share versus broader industry) and a continued reduction in operating costs, building on substantial cost-cutting through 2015.

Top 5 Low Price Stocks To Buy Right Now: Meta Financial Group Inc.(CASH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cashcoin (CURRENCY:CASH) traded up 40.8% against the dollar during the one day period ending at 16:00 PM E.T. on May 9th. Cashcoin has a market cap of $544,583.00 and $885.00 worth of Cashcoin was traded on exchanges in the last 24 hours. Over the last seven days, Cashcoin has traded up 68.3% against the dollar. One Cashcoin coin can currently be bought for $0.0114 or 0.00000123 BTC on popular exchanges.

  • [By Ethan Ryder]

    Cash Poker Pro (CURRENCY:CASH) traded flat against the U.S. dollar during the 24 hour period ending at 19:00 PM Eastern on April 15th. Over the last week, Cash Poker Pro has traded flat against the U.S. dollar. One Cash Poker Pro token can currently be bought for approximately $0.0543 or 0.00000604 BTC on major cryptocurrency exchanges. Cash Poker Pro has a total market cap of $0.00 and approximately $0.00 worth of Cash Poker Pro was traded on exchanges in the last day.

  • [By Logan Wallace]

    COPYRIGHT VIOLATION WARNING: “$4.13 EPS Expected for Meta Financial Group Inc. (CASH) This Quarter” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another website, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The legal version of this article can be accessed at www.tickerreport.com/banking-finance/3365508/4-13-eps-expected-for-meta-financial-group-inc-cash-this-quarter.html.

Top 5 Low Price Stocks To Buy Right Now: Equity Commonwealth(EQC)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Equity Commonwealth (NYSE:EQC) continued to steadily sell off its portfolio of real estate holdings, closing three more sales during the quarter, bringing its property count down to 13. As a result, cash flow kept declining. That trend doesn’t show any signs of ending given that the company has more properties on the market and doesn’t yet see a good opportunity to make acquisitions.

  • [By Stephan Byrd]

    HRPT Properties Trust (NYSE:EQC) had its price target boosted by investment analysts at JMP Securities to $33.00 in a report issued on Tuesday. The brokerage currently has a “market outperform” rating on the real estate investment trust’s stock. JMP Securities’ target price points to a potential upside of 4.04% from the company’s previous close.

Top 5 Low Price Stocks To Buy Right Now: Atara Biotherapeutics, Inc.(ATRA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Atara Biotherapeutics (NASDAQ:ATRA) posted its quarterly earnings data on Tuesday. The biotechnology company reported ($1.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.13), MarketWatch Earnings reports.

  • [By Chris Lange]

    Atara Biotherapeutics Inc. (NASDAQ: ATRA) shares surged on Friday after the firm announced that it received clearance from the U.S. Food and Drug Administration (FDA) to initiate two Phase 3 clinical studies. Specifically these mid-stage studies deal with tabelecleucel in patients with rituximab-refractory Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+PTLD).

  • [By Danny Vena, George Budwell, and Daniel Miller]

    With that in mind, we asked three Motley Fool contributors to identify growth stocks with intriguing potential that might not be on the radar of most investors. They pickedShopify Inc. (NYSE:SHOP), Atara Biotherapeutics, Inc. (NASDAQ:ATRA), and Criteo S.A. (NASDAQ:CRTO).

  • [By Max Byerly]

    Atara Biotherapeutics (NASDAQ:ATRA) SVP Derrell Porter sold 1,544 shares of the firm’s stock in a transaction on Tuesday, May 8th. The shares were sold at an average price of $40.15, for a total value of $61,991.60. Following the completion of the sale, the senior vice president now owns 12,500 shares in the company, valued at $501,875. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

  • [By Ethan Ryder]

    Atara Biotherapeutics (NASDAQ:ATRA) CEO Isaac E. Ciechanover sold 8,800 shares of the business’s stock in a transaction that occurred on Thursday, May 10th. The stock was sold at an average price of $39.85, for a total transaction of $350,680.00. Following the sale, the chief executive officer now owns 812,613 shares of the company’s stock, valued at $32,382,628.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Top 5 Low Price Stocks To Buy Right Now: Perceptron, Inc.(PRCP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Perceptron (NASDAQ: PRCP) and CyberOptics (NASDAQ:CYBE) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

Top 5 Low Price Stocks To Buy Right Now: Ellie Mae, Inc.(ELLI)

Advisors’ Opinion:

  • [By Brian Stoffel]

    We’ll cover each of those below for these five growth stocks.

    Company What it does…
    Mercadolibre(NASDAQ:MELI) Leading e-commerce player in Latin America
    Axon Enterprises(NASDAQ:AAXN) Develops products for police forces: TASERs, body cameras, and a database to store and analyze footage
    Shopify(NYSE:SHOP) Helps merchants create an e-commerce presence
    Ellie Mae(NYSE:ELLI) Offers platform to help streamline mortgage origination and refinancing business
    Paycom Solutions(NYSE:PAYC) Maintains and develops cloud solutions for HR departments

    Chart by author.

  • [By Dan Caplinger]

    Investors are scared about the state of the mortgage market, and that’s created consternation about mortgage software platform provider Ellie Mae (NYSE:ELLI) and its ability to keep producing the huge growth that it has seen in recent years. Concerns about rising interest rates have been around for a year now, but only recently have rate increases from the Federal Reserve on the short-term end of the yield curve actually started to have a substantial upward impact on longer-term fixed mortgage rates.

Leave a Reply

Your email address will not be published. Required fields are marked *